Search

Author/Creator Eyde, Nathan

1. 182 Highly potent fully human anti-VISTA antibodies – a new target checkpoint inhibitor against immunosuppressive myeloid cells. (10th December 2020)

Authors:
Guillaudeux, Thierry; Tarcha, Eric; Bader, Robert; Dutzar, Benjamin; Eyde, Nathan; Frazier, Emily; Jurchen, David; Lance, Remington; Loomis, Cristina; Lustig, Kurt; Ovechkina, Yulia; Peckham, David; Sridhar, Shaarwari; Xu, Mei; Iadonato, Shawn; Guillaudeux, Thierry; Posakony, Jeff
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A108
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention. (July 2017)

Authors:
Xie, Jennifer Y; De Felice, Milena; Kopruszinski, Caroline M; Eyde, Nathan; LaVigne, Justin; Remeniuk, Bethany; Hernandez, Pablo; Yue, Xu; Goshima, Naomi; Ossipov, Michael; King, Tamara; Streicher, John M; Navratilova, Edita; Dodick, David; Rosen, Hugh; Roberts, Ed; Porreca, Frank
Journal:
Cephalalgia
Issue:
Volume 37:Number 8(2017)
Page Start:
780
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Morphine effects within the rodent anterior cingulate cortex and rostral ventromedial medulla reveal separable modulation of affective and sensory qualities of acute or chronic pain. Issue 12 (December 2018)

Authors:
Gomtsian, Lusine; Bannister, Kirsty; Eyde, Nathan; Robles, Dagoberto; Dickenson, Anthony H.; Porreca, Frank; Navratilova, Edita
Journal:
Pain
Issue:
Volume 159:Issue 12(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗